US Bancorp’s MiNK Therapeutics INKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25K Hold
1,995
– – ﹤0.01% 3120
2026
Q2
$23.3K Buy
+1,995
New +$23.2K ﹤0.01% 3152

Other funds holding INKT

US Bancorp's INKT Position: Q3 2026 in Review

US Bancorp held its MiNK Therapeutics (INKT) position steady in Q3 2026 at 1,995 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #3120.

US Bancorp first reported a position in INKT in Q2 2026 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold INKT as of Q3 2026.

  • US Bancorp held 1,995 shares of MiNK Therapeutics worth $25K as of Q3 2026.
  • US Bancorp left its MiNK Therapeutics share count unchanged in Q3 2026.
  • MiNK Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #3120 holding.
  • US Bancorp first reported a position in MiNK Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q3 2026.

Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.